BioRender Icon

Ductal cell (cancerous) 1

Ductal cell (cancerous) 1 - Editable icon of Ductal cell (cancerous) 1
[{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f6df557cb160004933536/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f6df557cb160004933536/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d3f6df557cb160004933535/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d3f6df557cb160004933535/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3d0/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3d0/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3d1/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3d1/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3d2/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3d2/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3d3/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3d3/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3d4/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3d4/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3d5/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3d5/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3d6/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3d6/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3d7/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3d7/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3d8/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3d8/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3d9/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3d9/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3da/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3da/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3db/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3db/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3dc/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3dc/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3dd/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3dd/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3de/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3de/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3df/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3df/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3e0/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3e0/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3e1/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3e1/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3e2/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3e2/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3e3/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3e3/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3e4/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3e4/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3e5/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3e5/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3e6/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3e6/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3e7/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3e7/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3e8/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3e8/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3e9/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3e9/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3ea/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3ea/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3eb/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3eb/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3ec/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3ec/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3ed/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3ed/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3ee/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3ee/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3ef/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3ef/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3f0/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3f0/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3f1/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3f1/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3f2/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3f2/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3f3/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3f3/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3f4/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3f4/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3f5/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3f5/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3f6/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3f6/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3f7/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3f7/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3f8/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3f8/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3f9/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3f9/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3fa/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3fa/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3fb/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3fb/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3fc/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3fc/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3fd/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3fd/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3fe/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3fe/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a3ff/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a3ff/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a400/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a400/5d3f5e1a4d6c910004dc4420.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74875b6c0cbaec831a401/5d3f5e1a4d6c910004dc4420.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74875b6c0cbaec831a401/5d3f5e1a4d6c910004dc4420.png"}]
Use This Icon – Free
No credit card required to sign up.

This icon is fully editable in BioRender

  • Add text, shapes, & other icons
  • Search 50,000+ scientifically accurate icons
  • Recolor and rearrange every icon, line, & label
  • Export or share for any use case
Scientist Avatars

Join 4M+ scientists already making publication-ready figures

Go from icons to finished figure – in minutes

  • Search from 50,000+ scientifically accurate, peer-reviewed icons
  • Customize with labels, shapes, and additional icons – everything is completely editable
  • Export or share your figures with collaborators

Not quite the right icon? Discover more.

Search 50,000+ icons across 30+ life-science fields.

search icon
arrow-right
Keywords
duct,gland,ductal,glandular,cancer,breast duct,breast gland,cancer,tumor,tumour,cancerous,mass,mammary,duct cell,ductal,oncology
View More

Try a synonym, or sign up to request an icon from the app.

Image types

Ductal cell (cancerous) 1 icon JPEG

Ductal cell (cancerous) 1 icon PNG

Ductal cell (cancerous) 1 icon SVG

Ductal cell (cancerous) 1 icon GIF

Biorender Icon FAQs

How are scientists using the Ductal cell (cancerous) 1 icon in their work?

BioRender users often use the Ductal cell (cancerous) 1 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Epithelium.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Ductal cell (cancerous) 1 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Ductal cell (cancerous) 1 icon customizable in BioRender?

Most icons in BioRender, including the Ductal cell (cancerous) 1 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Ductal cell (cancerous) 1 icon for publication or presentations?

Yes, figures containing the Ductal cell (cancerous) 1 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Ductal cell (cancerous) 1 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Ductal cell (cancerous) 1 icon — especially those focused on Epithelium. You can search BioRender’s template library or add this icon manually to any canvas.

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Ductal cell (cancerous) 1 icon along with our library of more than 30,000 life science icons.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon